While some people find that supporting their antioxidant levels leads to better kidney function markers, glutathione is not a medical treatment for high creatinine
The research on who maintains weight loss after stopping GLP-1 medications consistently points to the same factors: those who sustain behavioral changes consistent meal structure, protein prioritization, reduced ultra-processed food intake maintain more of their weight loss than those who relied on pharmacological suppression alone
Rather than waiting for disease progression, clinicians are encouraged to initiate treatment intensification sooner, reducing long-term complications
Wegovy is made by Novo Nordisk and was approved by the FDA in 2021
You can find all the anti-oxidant products that I recommend in the DrDoniStore or in other stores
Research gaps to watch Important gaps include longterm randomized trials of multiingredient berberine stacks targeting sustained weight loss, standardized product formulations across trials, and large diverse studies that clarify interactions with common medications
